GLP-1 RA Drugs Not Associated With Increased Suicidal Thoughts

Given the past decade’s dramatic increase in glucagon-like peptide-1 receptor agonist (GLP-1 RA) use among people with type 2 diabetes, clinicians have raised concerns about whether the drugs, which target reward areas in the brain, could lead to suicidal thoughts.

Authors

Publication Details

Journal
JAMA
Published
2024-08-09
DOI
https://doi.org/10.1001/jama.2024.14872
Primary Topic
Pharmacology and Obesity Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

GLP-1 RA Drugs Not Associated With Increased Suicidal Thoughts

Samantha Anderer
JAMA
Pharmacology and Obesity Treatment
article

GLP-1 RA Drugs Not Associated With Increased Suicidal Thoughts

Samantha Anderer
article en

Abstract

Given the past decade’s dramatic increase in glucagon-like peptide-1 receptor agonist (GLP-1 RA) use among people with type 2 diabetes, clinicians have raised concerns about whether the drugs, which target reward areas in the brain, could lead to suicidal thoughts.

JAMAVol. 332(9)
Openalex Percentile: Top 87%
Pharmacology and Obesity Treatment
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

GLP-1 RA Drugs Not Associated With Increased Suicidal Thoughts — Samantha Anderer · JAMA (2024) | TGRS Research Map | TGRS